These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24361084)

  • 1. Factors associated with failure to complete isoniazid therapy for latent tuberculosis infection in children and adolescents.
    Chang SH; Eitzman SR; Nahid P; Finelli ML
    J Infect Public Health; 2014; 7(2):145-52. PubMed ID: 24361084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City.
    Li J; Munsiff SS; Tarantino T; Dorsinville M
    Int J Infect Dis; 2010 Apr; 14(4):e292-7. PubMed ID: 19656705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. House calls by community health workers and public health nurses to improve adherence to isoniazid monotherapy for latent tuberculosis infection: a retrospective study.
    Chang AH; Polesky A; Bhatia G
    BMC Public Health; 2013 Sep; 13():894. PubMed ID: 24073620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.
    Schein YL; Madebo T; Andersen HE; Arnesen TM; Dyrhol-Riise AM; Tveiten H; White RA; Winje BA
    BMC Infect Dis; 2018 Nov; 18(1):587. PubMed ID: 30453946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island.
    Kwara A; Herold JS; Machan JT; Carter EJ
    Chest; 2008 Apr; 133(4):862-8. PubMed ID: 18071014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the impact of patient self-selection on the costs to treat latent tuberculosis infection (LTBI) with isoniazid and transitional rifampin.
    Fluegge KR
    J Eval Clin Pract; 2014 Oct; 20(5):685-91. PubMed ID: 25087583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the role of primary care physicians in the treatment of latent tuberculosis: a population study.
    Rubinowicz A; Bartlett G; MacGibbon B; Greenaway C; Ronald L; Munoz M; Menzies D
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1449-54. PubMed ID: 25517810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Side Effects of Rifampin versus Isoniazid in Children.
    Diallo T; Adjobimey M; Ruslami R; Trajman A; Sow O; Obeng Baah J; Marks GB; Long R; Elwood K; Zielinski D; Gninafon M; Wulandari DA; Apriani L; Valiquette C; Fregonese F; Hornby K; Li PZ; Hill PC; Schwartzman K; Benedetti A; Menzies D
    N Engl J Med; 2018 Aug; 379(5):454-463. PubMed ID: 30067928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials.
    Campbell JR; Trajman A; Cook VJ; Johnston JC; Adjobimey M; Ruslami R; Eisenbeis L; Fregonese F; Valiquette C; Benedetti A; Menzies D
    Lancet Infect Dis; 2020 Mar; 20(3):318-329. PubMed ID: 31866327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
    Yang H; Yang Y; Hu ZD; Xia L; Liu XH; Yu X; Ma JY; Li T; Lu SH
    PLoS One; 2021; 16(6):e0253159. PubMed ID: 34115804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing adherence for latent tuberculosis infection therapy with health department-administered therapy.
    Cruz AT; Starke JR
    Pediatr Infect Dis J; 2012 Feb; 31(2):193-5. PubMed ID: 21979799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to Latent Tuberculosis Infection Treatment in a Population with a High Number of Refugee Children.
    Rogo T; Eleanya C; Hirway P; Pelland D; Lewis C; Dennehy P; Losikoff P
    R I Med J (2013); 2017 Feb; 100(2):34-38. PubMed ID: 28146598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful management of latent tuberculosis infection in an underserved community by a student-run free clinic.
    Peluso MJ; Hung A; Lukasiewicz A; Chang H; Ramallo J; Bartlett M; Friedland G; Ellis P
    J Health Care Poor Underserved; 2014 May; 25(2):837-62. PubMed ID: 24858889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil.
    Machado A; Finkmoore B; Emodi K; Takenami I; Barbosa T; Tavares M; Reis MG; Arruda S; Riley LW
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):719-25. PubMed ID: 19460247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive therapy compliance in pediatric tuberculosis - A single center experience.
    Santos JC; Silva JB; Rangel MA; Barbosa L; Carvalho I
    Pulmonology; 2020; 26(2):78-83. PubMed ID: 31427215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin.
    Lardizabal A; Passannante M; Kojakali F; Hayden C; Reichman LB
    Chest; 2006 Dec; 130(6):1712-7. PubMed ID: 17166986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial.
    Chan PC; Yang CH; Chang LY; Wang KF; Lu BY; Lu CY; Shao PL; Hsueh PR; Fang CT; Huang LM
    Int J Tuberc Lung Dis; 2012 May; 16(5):633-8. PubMed ID: 22410137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of pediatric latent tuberculosis infection in a community health center clinic.
    Young J; Edick T; Klee D; O'Connor ME
    Pediatr Infect Dis J; 2012 Sep; 31(9):e147-51. PubMed ID: 22531235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
    Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN
    Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.